322 related articles for article (PubMed ID: 26558612)
1. Novel Activities of Select NSAID R-Enantiomers against Rac1 and Cdc42 GTPases.
Oprea TI; Sklar LA; Agola JO; Guo Y; Silberberg M; Roxby J; Vestling A; Romero E; Surviladze Z; Murray-Krezan C; Waller A; Ursu O; Hudson LG; Wandinger-Ness A
PLoS One; 2015; 10(11):e0142182. PubMed ID: 26558612
[TBL] [Abstract][Full Text] [Related]
2. R-Ketorolac Targets Cdc42 and Rac1 and Alters Ovarian Cancer Cell Behaviors Critical for Invasion and Metastasis.
Guo Y; Kenney SR; Muller CY; Adams S; Rutledge T; Romero E; Murray-Krezan C; Prekeris R; Sklar LA; Hudson LG; Wandinger-Ness A
Mol Cancer Ther; 2015 Oct; 14(10):2215-27. PubMed ID: 26206334
[TBL] [Abstract][Full Text] [Related]
3. The R-enantiomer of ketorolac reduces ovarian cancer tumor burden in vivo.
Grimes MM; Kenney SR; Dominguez DR; Brayer KJ; Guo Y; Wandinger-Ness A; Hudson LG
BMC Cancer; 2021 Jan; 21(1):40. PubMed ID: 33413202
[TBL] [Abstract][Full Text] [Related]
4. A Novel Pharmacologic Activity of Ketorolac for Therapeutic Benefit in Ovarian Cancer Patients.
Guo Y; Kenney SR; Cook L; Adams SF; Rutledge T; Romero E; Oprea TI; Sklar LA; Bedrick E; Wiggins CL; Kang H; Lomo L; Muller CY; Wandinger-Ness A; Hudson LG
Clin Cancer Res; 2015 Nov; 21(22):5064-72. PubMed ID: 26071482
[TBL] [Abstract][Full Text] [Related]
5. Characterization of a Cdc42 protein inhibitor and its use as a molecular probe.
Hong L; Kenney SR; Phillips GK; Simpson D; Schroeder CE; Nöth J; Romero E; Swanson S; Waller A; Strouse JJ; Carter M; Chigaev A; Ursu O; Oprea T; Hjelle B; Golden JE; Aubé J; Hudson LG; Buranda T; Sklar LA; Wandinger-Ness A
J Biol Chem; 2013 Mar; 288(12):8531-8543. PubMed ID: 23382385
[TBL] [Abstract][Full Text] [Related]
6. Non-steroidal Anti-inflammatory Drugs Are Caspase Inhibitors.
Smith CE; Soti S; Jones TA; Nakagawa A; Xue D; Yin H
Cell Chem Biol; 2017 Mar; 24(3):281-292. PubMed ID: 28238723
[TBL] [Abstract][Full Text] [Related]
7. Maspin controls mammary tumor cell migration through inhibiting Rac1 and Cdc42, but not the RhoA GTPase.
Shi HY; Stafford LJ; Liu Z; Liu M; Zhang M
Cell Motil Cytoskeleton; 2007 May; 64(5):338-46. PubMed ID: 17301947
[TBL] [Abstract][Full Text] [Related]
8. The role of Rho GTPases' substrates Rac and Cdc42 in osteoclastogenesis and relevant natural medicinal products study.
Liu Y; Dou Y; Yan L; Yang X; He B; Kong L; Smith W
Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32578854
[TBL] [Abstract][Full Text] [Related]
9. Dual Actions of Ketorolac in Metastatic Ovarian Cancer.
Hudson LG; Cook LS; Grimes MM; Muller CY; Adams SF; Wandinger-Ness A
Cancers (Basel); 2019 Jul; 11(8):. PubMed ID: 31344967
[TBL] [Abstract][Full Text] [Related]
10. DEF6, a novel PH-DH-like domain protein, is an upstream activator of the Rho GTPases Rac1, Cdc42, and RhoA.
Mavrakis KJ; McKinlay KJ; Jones P; Sablitzky F
Exp Cell Res; 2004 Apr; 294(2):335-44. PubMed ID: 15023524
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of Cdc42 and Rac1 activities in pheochromocytoma, the adrenal medulla tumor.
Croisé P; Brunaud L; Tóth P; Gasman S; Ory S
Small GTPases; 2017 Apr; 8(2):122-127. PubMed ID: 27355516
[TBL] [Abstract][Full Text] [Related]
12. MeHg affects the activation of FAK, Src, Rac1 and Cdc42, critical proteins for cell movement in PDGF-stimulated SH-SY5Y neuroblastoma cells.
Hernández AJA; Reyes VL; Albores-García D; Gómez R; Calderón-Aranda ES
Toxicology; 2018 Feb; 394():35-44. PubMed ID: 29197552
[TBL] [Abstract][Full Text] [Related]
13. Unraveling the molecular mechanism of interactions of the Rho GTPases Cdc42 and Rac1 with the scaffolding protein IQGAP2.
Ozdemir ES; Jang H; Gursoy A; Keskin O; Li Z; Sacks DB; Nussinov R
J Biol Chem; 2018 Mar; 293(10):3685-3699. PubMed ID: 29358323
[TBL] [Abstract][Full Text] [Related]
14. Discovery and characterization of small molecule Rac1 inhibitors.
Arnst JL; Hein AL; Taylor MA; Palermo NY; Contreras JI; Sonawane YA; Wahl AO; Ouellette MM; Natarajan A; Yan Y
Oncotarget; 2017 May; 8(21):34586-34600. PubMed ID: 28410221
[TBL] [Abstract][Full Text] [Related]
15. Metformin impairs Rho GTPase signaling to induce apoptosis in neuroblastoma cells and inhibits growth of tumors in the xenograft mouse model of neuroblastoma.
Kumar A; Al-Sammarraie N; DiPette DJ; Singh US
Oncotarget; 2014 Nov; 5(22):11709-22. PubMed ID: 25365944
[TBL] [Abstract][Full Text] [Related]
16. Multiple factors confer specific Cdc42 and Rac protein activation by dedicator of cytokinesis (DOCK) nucleotide exchange factors.
Kulkarni K; Yang J; Zhang Z; Barford D
J Biol Chem; 2011 Jul; 286(28):25341-51. PubMed ID: 21613211
[TBL] [Abstract][Full Text] [Related]
17. Stereoselective inhibitory effect of flurbiprofen, ibuprofen and naproxen on human organic anion transporters hOAT1 and hOAT3.
Honjo H; Uwai Y; Aoki Y; Iwamoto K
Biopharm Drug Dispos; 2011 Dec; 32(9):518-24. PubMed ID: 22072415
[TBL] [Abstract][Full Text] [Related]
18. The Intrinsic GDP/GTP Exchange Activities of Cdc42 and Rac1 Are Critical Determinants for Their Specific Effects on Mobilization of the Actin Filament System.
Aspenström P
Cells; 2019 Jul; 8(7):. PubMed ID: 31330900
[TBL] [Abstract][Full Text] [Related]
19. Different roles of the small GTPases Rac1, Cdc42, and RhoG in CALEB/NGC-induced dendritic tree complexity.
Schulz J; Franke K; Frick M; Schumacher S
J Neurochem; 2016 Oct; 139(1):26-39. PubMed ID: 27412363
[TBL] [Abstract][Full Text] [Related]
20. RAC1 GTP-ase signals Wnt-beta-catenin pathway mediated integrin-directed metastasis-associated tumor cell phenotypes in triple negative breast cancers.
De P; Carlson JH; Jepperson T; Willis S; Leyland-Jones B; Dey N
Oncotarget; 2017 Jan; 8(2):3072-3103. PubMed ID: 27902969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
